Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells

International Journal of Cancer

Volumn 76, Issue 1, 1998, Pages 99-104

  Qiao, Liang ^a   Shiff, Steven J ^b,c   Rigas, Basil ^b,c  

^a NEW YORK METHODIST HOSPITAL   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CARCINOMA CELL; CELL CYCLE; CELL KINETICS; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DIVISION; COLONIC NEOPLASMS; CYCLIN B; CYCLIN D1; CYCLINS; HT29 CELLS; HUMANS; SULINDAC;

EID: 0031980574     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980330)76:1<99::AID-IJC16>3.0.CO;2-B     Document Type: Article

References (30)

1. ARBER, N., HIBSHOOSH, H., MOSS, S.F., SUTTER, T., ZHANG, Y., BEGG, M., WANG, S., WEINSTEIN, I.B. and HOLT, P.R., Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology, 110, 669-674 (1996).
2. BATES, S. and PETERS, G., Cyclin D1 as a cellular proto-oncogene. Semin. Cancer Biol., 6, 73-82 (1995).
3. 1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res., 56, 733-737 (1996).
4. GIARDIELLO, P.M., HAMILTON, S.R., KRUSH, A.J., PIANTADOSI, S., HYLIND, L.M., CELANO, P., BOOKER, S.V., ROBINSON, C.R. and OFFERHAUS, G.J., Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl J. Med., 328, 1313-1316 (1993).
5. GIOVANNUCCI, E., RIMM, E.B., STAMPFER, M.J., COLDITZ, G.A., ASCHERIO, A. and WILLETT, W.C., Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. intern. Med., 121, 241-246 (1994).
6. GOLDBERG, Y., NASSIF, I.I., PITTAS, A., TSAI, L.-L., DYNLACHT, B.D., RIGAS, B. and SHIFF, S.J., The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene, 12, 893-901 (1996).
7. GONG, J., ARDELT, B., TRAGANOS, F. and DARZYNKIEWICZ, Z., Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res., 54, 4285-4288 (1994).
8. GONG, J., BHATIA, U., TRAGANOS, F. and DARZYNKIEWICZ, Z., Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry. Leukemia, 9, 893-899 (1995a).
9. GONG, J., TRAGANOS, F. and DARZYNKIEWICZ, Z., Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication. Cell Growth Differ., 6, 1485-1493 (19956).
10. GONG, J., TRAGANOS, F. and DARZYNKIEWICZ, Z., Threshold expression of cyclin E but not D type cyclins characterizes normal and tumour cells entering S phase. Cell Proliferation, 28, 337-346 (1995c).
11. GRIDLEY, G., MCLAUGHLIN, J., EKBOM, A., KLARESKOG, L., ADAMI, H., HOOVER, R. and FRAUMENI, J.J., Incidence of cancer among patients with rheumatoid arthritis. J. nat. Cancer Inst., 85, 307-310 (1993).
12. HANIF, R., PITTAS, A., FENG, Y., KOUTSOS, M.I., STAIANO-COICO, L., SHIFF, S.J. and RIGAS, B., Effects of nonsteroidal antiinflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52, 237-245 (1996).
13. JÄNICKE, R.U., LIN, X.Y., LEE, F.H.H. and PORTER, A.G., Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-myc-dependent apoptosis. Mol. cell. Biol., 16, 5245-5253 (1996).
14. KITAHARA, K., YASUI, W., KUNIYASU, H., YOKOZAKI, H., AKAMA, Y., YUNOTANI, S., HISATSUGU, T. and TAHARA, E., Concurrent amplification of cyclin E and cdk2 genes in colorectal carcinomas. Int. J. Cancer, 62, 25-28 (1995).
15. KRANENBURG, O., VAN DER EB, A.J. and ZANTEMA, A., Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J., 15, 46-54 (1996).
16. LEACH, F.S., ELLEDGE, S.J., SHERR, C.J., WILLSON, J.K.V., MARKOWITZ, S., KINZLER, K.W. and VOGELSTEIN, B., Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53, 1986-1989 (1993).
17. MORGAN, D.O., Principles of CDK regulation. Nature (Lond.), 374, 131-134 (1995).
18. MUMBERG, D., HAAS, K., MOROY, T., NIEDENTHAL, R., HEGEMANN, J.H., FUNK, M. and MULLER, R., Uncoupling of DNA replication and cell cycle progression by human cyclin E. Oncogene, 13, 2493-2497 (1996).
19. PIAZZA, G.A., RAHM, A.L.K., KRUTZSCH, M., SPERL, G., PARANKA, N.S., GROSS, P.H., BRENDEL, K., BURT, R.W., ALBERTS, D.S., PAMUKCU, R. and AHNEN, D.J., Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55, 3110-3116 (1995).
20. PINES, J., Cyclins, CDKs and cancer. Semin. Cancer Biol., 6, 63-72 (1995).
21. QIAO, L., HANIF, R., SPHICAS, E., SHIFF, S.J. and RIGAS, B., Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. Biochem. Pharmacol. (1997a) (In press).
22. QIAO, L., SHIFF, S.J. and RIGAS, B., Sulindac sulfide inhibits the proliferation of colon cancer cells - diminished expression of the proliferation markers PCNA and Ki-67. Cancer Lett., 115, 229-234 (1997b).
23. 1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637. Proc. nat. Acad. Sci. (Wash.), 93, 5941-5946 (1996).
24. 1 cyclins. Cell, 73, 1059-1065 (1993).
25. 1 phase progression: cycling on cue. Cell, 79, 551-555 (1994).
26. SHIFF, S.J., KOUTSOS, M.I., QIAO, L. and RIGAS, B., Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res., 222, 179-188 (1996).
27. SHIFF, S.J., QIAO, L., TSAI, L.-L. and RIGAS, B., Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. clin. Invest., 96, 491-503 (1995).
28. SOFER-LEVI, Y. and RESNITZKY, D., Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene, 13, 2431-2437 (1996).
29. WADDELL, W.R. and LOUGHRY, R.W., Sulindac for polyposis of the colon. J. surg. Oncol., 24, 83-87 (1983).
30. WANG, A., YOSHIMI, N., SUZUI, M., YAMAUCHI, A., TARAO, M. and MORI, H., Different expression patterns of cyclins A, D1 and E in human colorectal cancer. J. Cancer Res. clin. Oncol., 122, 122-126 (1996).